A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure
NanoCor Therapeutics is a biotechnology company founded to create a viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (CHF). The company was spun off from AsklÃapios BioPharmaceutical, Inc.